PR Newswire
WILMINGTON, Del., Feb. 18, 2026
Summary:
Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the hydrophobic interaction chromatography market.
WILMINGTON, Del., Feb. 18, 2026 /PRNewswire/ — Allied Market Research published a report, titled, «Hydrophobic Interaction Chromatography Market by Product and Service (Product and Service), Sample Type (Monoclonal Antibodies, Vaccines, Cell Culture Sample, Plasma & Serum Sample, and Others), Application (Protein & Antibody Purification, Vaccine Development, Drug Discovery, and Food & Dietary Supplement Development), and End User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations & Contract Manufacturing Organizations, Research & Academic Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the «hydrophobic interaction chromatography market» was valued at $461.9 million in 2023, and is projected to reach $952.9 million by 2033, growing at a CAGR of 7.5% from 2024 to 2033.
https://mma.prnewswire.com/media/636519/5813186/Allied_Market_Research_Logo.jpg
Request Sample of the Report on Hydrophobic Interaction Chromatography Market Forecast 2033 –
https://www.alliedmarketresearch.com/request-sample/A325383
Prime determinants of growth
Increase in R&D expenditure in biopharmaceuticals, surge in demand for biologics & monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the hydrophobic interaction chromatography market. However, the lack of a skilled workforce and high initial investment & operating costs restrict market growth. Moreover, growth opportunities in emerging markets and technological advancements in hydrophobic interaction chromatography (HIC) are expected to open new avenues in the coming years.
Report coverage & details:
Report
Coverage
Details
Forecast
Period
2024-2033
Base Year 2023
Market Size
in 2023
$461.9 million
Market Size
in 2033
$952.9 million
CAGR 7.5 %
Segments
covered
Product & Service, Sample Type, Application, End User, and Region
Drivers
• Increase in R&D expenditure in biopharmaceuticals,
• Rise in demand for biologics and monoclonal antibodies (mAbs)
• Rise in adoption of biosimilars
Opportunities
• Growth opportunities in emerging markets
• Technological advancements in hydrophobic interaction
chromatography (HIC)
Restraint
• Lack of a skilled workforce
• High initial investment and operating costs
Want to Explore More, Connect to our Analyst –
https://www.alliedmarketresearch.com/connect-to-analyst/A325383
The product segment held the largest market share in 2023.
By product and service, the product segment held the largest market share in 2023, accounting for more than four-fifths of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is expected to register the highest CAGR of 7.6% during the forecast period. This is attributed to growing demand for high-quality chromatography products, particularly in biopharmaceuticals and biotechnology industries. The increasing use of hydrophobic interaction chromatography for the purification of monoclonal antibodies, therapeutic proteins, and vaccines is driving the demand for advanced HIC resins and other chromatography products.
The monoclonal antibodies segment held the largest market share in 2023.
By sample type, the monoclonal antibodies segment held the largest market share in 2023, accounting for around two-fifths of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is expected to register the highest CAGR of 7.9% during the forecast period. This is attributed to the increase in demand for monoclonal antibodies in the treatment of cancer, autoimmune disorders, and other chronic diseases, which drives the need for efficient and reliable purification methods such as hydrophobic interaction chromatography (HIC).
The protein and antibody purification segment held the largest market share in 2023.
By application, the protein and antibody purification segment held the largest market share in 2023, accounting for more than two-fifths of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the increase in demand for high-purity proteins and antibodies in the biopharmaceutical industry, particularly for the production of monoclonal antibodies, therapeutic proteins, and vaccines. In addition, the growing focus on biologics, biosimilars, and personalized medicine, along with stringent regulatory requirements for purity in biologics manufacturing, further contributes to the segment’s growth.
The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.
By end user, the pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023, accounting for half of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the significant role of these companies play in the production of biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, which require efficient purification techniques like hydrophobic interaction chromatography (HIC).
However, the contract research organizations and contract manufacturing organizations segment is expected to register the highest CAGR of 7.9% during the forecast period. This is attributed to the growing trend of outsourcing in the pharmaceutical and biotechnology industries, where CROs and CMOs are increasingly relied upon for their expertise in research, development, and manufacturing processes.
North America held the largest market share in 2023.
North America dominated the market share in 2023, accounting for around two-fifths of the hydrophobic interaction chromatography market revenue, owing to the presence of a well-established and advanced biopharmaceutical industry. Strong presence of pharmaceutical and biotechnology companies that extensively use hydrophobic interaction chromatography (HIC) for the purification of biologics, including monoclonal antibodies, therapeutic proteins, and vaccines.
However, Asia-Pacific is expected to register the highest CAGR of 8.2% during the forecast period owing to the increase in demand for biologics, biosimilars, and therapeutic proteins is driving the adoption of advanced purification technologies such as hydrophobic interaction chromatography (HIC). In addition, the region benefits from lower production costs, expanding contract research and manufacturing services, and growing investments in healthcare infrastructure and R&D. These factors, combined with supportive government policies and an increasing focus on improving regulatory standards, are contributing to the region’s robust growth in the HIC market.
For Purchase Related Queries/Enquiry –
https://www.alliedmarketresearch.com/purchase-enquiry/A325383
What Is the Current Market Size and How Is the Market Expected to Grow?
There is an increase in adoption of hydrophobic interaction chromatography techniques in research, development, and manufacturing sectors. This is attributed to increase in production of biologic drugs that require advanced and reliable separation methods to achieve the purity levels required for therapeutic use. Rise in demand for biologics and monoclonal antibodies increase the need for efficient purification solutions. Also, ongoing advancements in chromatography media, resins, and column technologies boost the demand for hydrophobic interaction chromatography for its end users
North America holds a leading position due to a presence of advanced biopharmaceutical ecosystem and research infrastructure. The Asia-Pacific region is anticipated to register the fastest growth rate attributed to rise in biomanufacturing investments, expansion of clinical research activities, and surge in focus on developing domestic life sciences industries.
Who Are the Primary End Users Driving Market Adoption?
Pharmaceutical and biopharmaceutical companies focus on the development and large-scale manufacturing of biologics including monoclonal antibodies, therapeutic proteins, and vaccines. This increases the need for hydrophobic interaction chromatography within the industry. Contract research organizations and contract manufacturing organizations also use hydrophobic interaction chromatography. These service providers offer outsourced research, development, and manufacturing services to pharmaceutical and biotechnology firms. They help support protein purification, analytical testing, and process development.
Academic and research institutes also use hydrophobic interaction chromatography for separating and characterizing proteins, antibodies, and biomolecules. In addition, hydrophobic interaction chromatography is also adopted in diagnostic laboratories, biotechnology startups, and specialized research labs for analytical testing and purification tasks.
Major Global Key Players:
Major key players that operate in the global Hydrophobic Interaction Chromatography Market are
- Waters Corporation,
- Tosoh Corporation,
- Merck KGaA,
- Sepax Technologies, Inc.,
- Agilent Technologies, Inc.,
- Bio-Rad Laboratories, Inc.,
- Geno Technology, Inc.,
- KNAUER Wissenschaftliche Gerate GmbH,
- Thermo Fisher Scientific Inc.,
- Danaher Corporation,
- Sartorius AG
Explore AMR’s Extensive Ongoing Coverage on Life Science Industry:
Wound Irrigation System Market –
https://www.alliedmarketresearch.com/wound-irrigation-system-market-A43041
Alcoholic Hepatitis Treatment Market –
https://www.alliedmarketresearch.com/alcoholic-hepatitis-treatment-market-A234521
Medical Device Outsourcing Market –
https://www.alliedmarketresearch.com/medical-devices-outsourcing-market
Teleradiology Market –
https://www.alliedmarketresearch.com/teleradiology-market
Next Generation Sequencing Market –
https://www.alliedmarketresearch.com/next-generation-sequencing-market
Transcriptomics Market –
https://www.alliedmarketresearch.com/transcriptomics-market
Newborn Screening Market –
https://www.alliedmarketresearch.com/newborn-screening-market
AVENUE – A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library on Avenue, designed specifically to offer cost-effective, one-stop solutions for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.To find out more, visit www. Alliedmarketresearch.com or follow us on Twitter, LinkedIn and Facebook.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Logo – https://mma.prnewswire.com/media/636519/5813186/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/hydrophobic-interaction-chromatography-market-to-reach-952-9-million-globally-by-2033-at-7-5-cagr-allied-market-research-302691629.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…